Mainz Biomed N.V. (MYNZ)
Delisted
16 Mar 2026
NASDAQ (CM) NASDAQ (CM) Primary $
0. 70
-0.04
-5.0719%
$
2.86M Market Cap
- P/E Ratio
- Div Yield
21,831 Volume
-1.69 Eps
$ 0.74
Previous Close Investors:
Day Range
0.63 0.72
Year Range
0.55 5.34
Want to track MYNZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mainz Biomed N.V. (MYNZ) Statistics
Valuation metrics
Market Cap 2.86M
Enterprise value 4.29M
Trailing P/E (ttm) -0.02
Forward P/E -1.14
PEG ratio -1.14
Price/Sales (ttm) 16.01
Price/Book (mrq) 1.37
Enterprise Value/Revenue 6.49
Enterprise Value/EBITDA -0.27
Overview
Shares outstanding 4.09M
Float 3.46M
Shares short 467.58K
% Held by insiders 0.17%
% Held by institutions 0.13%
Average volume (10 days) 173.57K
Average volume (90 days) 494.53K
Price summary
52-Week low 0.55
52-Week high 5.34
Beta 0.32
50-Day moving average 0.92
200-Day moving average 1.35
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 3 Dec 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Dec 2023
Profitability
Profit margin 0.64%
Operating margin -28.22%
Operational effectiveness
Return on assets -1.14%
Return on equity -3.58%
Income Statement
Revenue (ttm) 659.93K
Revenue per share (ttm) 0.29
Quarterly revenue growth (yoy) -0.45%
Gross profit (ttm) 445.43K
EBITDA -16.15M
Net income to common (ttm) -18.97M
Diluted EPS (ttm) -5.28
Quarterly earnings growth (yoy) 0.11%
Balance Sheet
Total cash (mrq) 1.91M
Total cash per share (mrq) 0.47
Total debt (mrq) 3.09M
Total Debt/Equity (mrq) 122.65
Current ratio (mrq) 0.52%
Book value per share (mrq) 0.62
Cash Flow
Cash flow statement -15.46M
Levered free cash flow (LFCF) -8.19M
